Related references
Note: Only part of the references are listed.Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses
I Galindo et al.
ANTIVIRAL RESEARCH (2021)
Evidence for distinct mechanisms of small molecule inhibitors of filoviral entry
Adam Schafer et al.
PLOS PATHOGENS (2021)
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
Courtney L. Finch et al.
MICROORGANISMS (2021)
Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2
Michal Stefanik et al.
MICROORGANISMS (2021)
Emerging mechanisms of drug-induced phospholipidosis
Bernadette Breiden et al.
BIOLOGICAL CHEMISTRY (2020)
Ebola
Heinz Feldmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Update on naturally occurring novel arylnaphthalenes from plants
Shoujie Li et al.
PHYTOCHEMISTRY REVIEWS (2020)
Filovirus Antiviral Activity of Cationic Amphiphilic Drugs is Associated with Lipophilicity and Ability To Induce Phospholipidosis
Antonia P. Gunesch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections
Irina N. Gaisina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Recent successes in therapeutics for Ebola virus disease: no time for complacency
Patrick L. Iversen et al.
LANCET INFECTIOUS DISEASES (2020)
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
Yuan-Lin Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
Allan Sauvat et al.
CELL DEATH & DISEASE (2020)
Drug Repurposing for Ebola Virus Disease: Principles of Consideration and the Animal Rule
Jane P. F. Bai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
Michela Mazzon et al.
VIRUSES-BASEL (2019)
A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells
Corina M. Stewart et al.
VIRUSES-BASEL (2019)
An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion
Lucie Feneant et al.
PLOS ONE (2019)
Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro
Anne Sadewasser et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus
Alicia Martinez-Lopez et al.
EBIOMEDICINE (2019)
Previously Uncharacterized Vacuolar-type ATPase Binding Site Discovered from Structurally Similar Compounds with Distinct Mechanisms of Action
Andrew C. Wang et al.
ACS CHEMICAL BIOLOGY (2019)
Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action
Zivota Selakovic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence
Christopher H. Choy et al.
JOURNAL OF CELL SCIENCE (2018)
Identification of Potent Ebola Virus Entry Inhibitors with Suitable Properties for in Vivo Studies
Hu Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Apilimod, a candidate anticancer therapeutic, arrests not only PtdIns(3,5)P2 but also PtdIns5P synthesis by PIKfyve and induces bafilomycin A1-reversible aberrant endomembrane dilation
Diego Sbrissa et al.
PLOS ONE (2018)
Novel amodiaquine derivatives potently inhibit Ebola virus infection
Yasuteru Sakurai et al.
ANTIVIRAL RESEARCH (2018)
Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H+)-ATPase Inhibition
Aaron Lindstrom et al.
CHEMMEDCHEM (2018)
Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection
Che-Ming Jack Hu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
Qinghua Cui et al.
VIRUSES-BASEL (2018)
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Youichi Suzuki et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection
Sean Ekins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa
Hong-Jie Zhang et al.
JOURNAL OF NATURAL PRODUCTS (2017)
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
Elizabeth A. Nelson et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus
Che-Ming Jack Hu et al.
SCIENTIFIC REPORTS (2017)
Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor
Han Cheng et al.
ANTIVIRAL RESEARCH (2017)
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors
Manu Anantpadma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Novel Small Molecule Entry Inhibitors of Ebola Virus
Arnab Basu et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Analysis of Ebola Virus Entry Into Macrophages
Franziska Dahlmann et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Discovery of a Small-Molecule Probe for V-ATPase Function
Leslie N. Adrich et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process
Cristiano Salata et al.
PATHOGENS AND DISEASE (2015)
Anti-Ebola Activity of Diazachrysene Small Molecules
Zivota Selakovic et al.
ACS INFECTIOUS DISEASES (2015)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
ER Contact Sites Define the Position and Timing of Endosome Fission
Ashley A. Rowland et al.
CELL (2014)
The Complex Ultrastructure of the Endolysosomal System
Judith Klumperman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
Luis M. Bimbo et al.
ACS NANO (2013)
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses
Hui-Wen Chen et al.
ANTIVIRAL RESEARCH (2013)
AMP-Activated Protein Kinase Is Required for the Macropinocytic Internalization of Ebolavirus
Andrew S. Kondratowicz et al.
JOURNAL OF VIROLOGY (2013)
Ebola Virus Exploits a Monocyte Differentiation Program To Promote Its Entry
Osvaldo Martinez et al.
JOURNAL OF VIROLOGY (2013)
Ebola virus entry requires the host-programmed recognition of an intracellular receptor
Emily Happy Miller et al.
EMBO JOURNAL (2012)
Design, synthesis and biological evaluation of novel glycosylated diphyllin derivatives as topoisomerase II inhibitors
Da-Kuo Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression
Kerstin Gnirss et al.
VIROLOGY (2012)
The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections
Konstantin H. Muller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The Tyro3 Receptor Kinase Axl Enhances Macropinocytosis of Zaire Ebolavirus
Catherine L. Hunt et al.
JOURNAL OF VIROLOGY (2011)
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection
Marceline Cote et al.
NATURE (2011)
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1
Jan E. Carette et al.
NATURE (2011)
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase
Roberto Zoncu et al.
SCIENCE (2011)
Ebola Virion Attachment and Entry into Human Macrophages Profoundly Effects Early Cellular Gene Expression
Victoria Wahl-Jensen et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Human host factors required for influenza virus replication
Renate Koenig et al.
NATURE (2010)
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
Mohammad F. Saeed et al.
PLOS PATHOGENS (2010)
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
Asuka Nanbo et al.
PLOS PATHOGENS (2010)
Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus
Mohammad F. Saeed et al.
PLOS PATHOGENS (2008)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
K Chandran et al.
SCIENCE (2005)
Share Paper
